Beyond Lutetium and Actinium: The Next Generation of Isotopes in the Radiopharmaceutical Market
While Lutetium-177 and Actinium-225 are currently capturing the lion's share of headlines and venture capital, they are merely the tip of the spear. The Radiopharmaceutical Market boasts a deep and highly diverse pipeline of emerging radioactive isotopes. Researchers are actively exploring novel elements that offer different half-lives, decay energies, and chemical bonding properties, paving...
0 Commentarios 0 Acciones 401 Views 0 Vista previa
SocioMint https://sociomint.com